DEPDC5 mutations in families presenting as autosomal dominant nocturnal frontal lobe epilepsy
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To study the prevalence of DEPDC5 mutations in a series of 30 small European families with a phenotype compatible with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE). METHODS: Thirty unrelated families referred with ADNFLE were recruited in France, Italy, Germany, Belgium, and Norway. Whole-exome sequencing was performed in 10 probands and direct sequencing of the DEPDC5 coding sequence in 20 probands. Testing for nonsense-mediated messenger RNA decay (NMD) was performed in lymphoblastic cells. RESULTS: Exome sequencing revealed a splice acceptor mutation (c.2355-2A>G) in DEPDC5 in the proband of a German family. In addition, 3 nonsense DEPDC5 mutations (p.Arg487*, p.Arg1087*, and p.Trp1369*) were detected in the probands of 2 French and one Belgian family. The nonsense mutations p.Arg487* and p.Arg1087* were targeted by NMD, leading to the degradation of the mutated transcripts. At the clinical level, 78% of the patients with DEPDC5 mutations were drug resistant. CONCLUSIONS: DEPDC5 loss-of-function mutations were found in 13% of the families with a presentation of ADNFLE. The rate of drug resistance was high in patients with DEPDC5 mutations. Small ADNFLE pedigrees with DEPDC5 mutations might actually represent a part of the broader familial focal epilepsy with variable foci phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bar-Peled, L., Chantranupong, L., Cherniack, A. D., Chen, W. W., Ottina, K. A., Grabiner, B. C., Spear, E. D., Carter, S. L., Meyerson, M., & Sabatini, D. M. (2013) · Science · doi:10.1126/science.1232044 · Cited by 1,080 · cited 1×
“It was recently shown thatDEPDC5 has a GAP (GTPase-activating protein) activity(10) and is part of a complex that negatively regulates mTORC1.(11) Here we have evaluated the importance of DEPDC5 in ADNFLE by assessing the mutation prevalence in 30 families.”
BackgroundHeron, S. E., Smith, K. R., Bahlo, M., Nobili, L., Kahana, E., Licchetta, L., Oliver, K. L., Mazarib, A., Afawi, Z., Korczyn, A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2440 · Cited by 411
Mutations in DEPDC5 cause familial focal epilepsy with variable foci
Dibbens, L. M., de Vries, B., Donatello, S., Heron, S. E., Hodgson, B. L., Chintawar, S., Crompton, D. E., Hughes, J. N., Bellows, S. T., Klein, K. M., et al. (2013) · Nature Genetics · doi:10.1038/ng.2599 · Cited by 373 · cited 6×
“broader phenotype of FFEVF, with the currently recognized affected family members having only NFLE.(7) So far, 23DEPDC5mutations have been reported in familial focal epilepsies, including the 4 mutations found in this study, 2 of which are recurrent (figure 2A).”
BackgroundInfluentialMutations of DEPDC5 cause autosomal dominant focal epilepsies
Ishida, S., Picard, F., Rudolf, G., Noé, E., Achaz, G., Thomas, P., Genton, P., Mundwiller, E., Wolff, M., Marescaux, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2601 · Cited by 269 · cited 2×
“The 2 patients with NFLE of our previously describedDEPDC5-positive ADNFLE family (referred as family B) were also drug resistant.(3,8) Among the 4 DEPDC5-positive ADNFLE families of the present study, 60% of the patients, all of whom were drug resistant, experienced rare diurnal seizures.”
BackgroundMethodSelf-citation
Cited by
Definition and diagnostic criteria of sleep-related hypermotor epilepsy
Tinuper, P., Bisulli, F., Cross, J. H., Hesdorffer, D., Kahane, P., Nobili, L., Provini, F., Scheffer, I. E., Tassi, L., Vignatelli, L., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002666 · Cited by 306
Self-citationFamilial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations
Baulac, S., Ishida, S., Marsan, E., Miquel, C., Biraben, A., Nguyen, D. K., Nordli, D., Cossette, P., Nguyen, S., Lambrecq, V., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24368 · Cited by 293
Self-citationRiney, K., Bogacz, A., Somerville, E., Hirsch, E., Nabbout, R., Scheffer, I. E., Zuberi, S. M., Alsaadi, T., Jain, S., French, J., et al. (2022) · Epilepsia · doi:10.1111/epi.17240 · Cited by 287
Epilepsy in the mTORopathies: opportunities for precision medicine
Moloney, P. B., Cavalleri, G. L., & Delanty, N. (2021) · Brain Communications · doi:10.1093/braincomms/fcab222 · Cited by 125
mTOR signaling pathway genes in focal epilepsies
Baulac, S. (2016) · Progress in Brain Research · doi:10.1016/bs.pbr.2016.04.013 · Cited by 84
Self-citation
Metadata
- Authors
- Picard, F., Makrythanasis, P., Navarro, V., Ishida, S., de Bellescize, J., Ville, D., Weckhuysen, S., Fosselle, E., Suls, A., De Jonghe, P., Vasselon Raina, M., Lesca, G., Depienne, C., An-Gourfinkel, I., Vlaicu, M., Baulac, M., Mundwiller, E., Couarch, P., Combi, R., Ferini-Strambi, L., Gambardella, A., Antonarakis, S. E., Leguern, E., Steinlein, O., & Baulac, S.
- Venue
- Neurology
- Published
- 2014-06-10
- Volume
- 82
- Issue
- 23
- Pages
- 2101-2106
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2105316253
- Cited by
- 146
- References
- 4
- FWCI
- 11.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: DEPDC5 mutations in families presenting as autosomal dominant nocturnal frontal lobe epilepsy. https://app.cochat.ai/papers/10.1212/wnl.0000000000000488
- The paper
- Picard, F., Makrythanasis, P., Navarro, V., Ishida, S., de Bellescize, J., Ville, D., Weckhuysen, S., Fosselle, E., Suls, A., De Jonghe, P., Vasselon Raina, M., Lesca, G., Depienne, C., An-Gourfinkel, I., Vlaicu, M., Baulac, M., Mundwiller, E., Couarch, P., Combi, R., . . . Baulac, S. (2014). DEPDC5 mutations in families presenting as autosomal dominant nocturnal frontal lobe epilepsy. Neurology. https://doi.org/10.1212/wnl.0000000000000488
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.